Studies looking at association of reduced lung function tests with systemic inflammatory markers have shown that COPD patients have higher levels of circulating inflammatory markers including leukocytes, fibrinogen, ESR, CRP, tumor necrosis factor-α, suggesting that systemic inflammation may have a role in COPD [11]. This evidence concerns the gene ESR1 and chronic obstructive pulmonary disease.